Paul Flores

Paul Flores is the President at Medica.ai since February 2016, leading efforts to rebuild healthcare through a secure blockchain and decentralized applications (DApps) for electronic medical records. Additionally, Paul serves as Director at Lek Pharmaceuticals d.d., a subsidiary of Sandoz, and as a part-time Quality & Safety Surveyor and Instructor for the ECRI Institute, focusing on improving patient care through evidence-based research. Prior experience includes roles as Executive Medical Director at Concord International Hospital, Co-Founder of a private specialist group, and Medical Officer at Strides Pharma Global Pte Ltd. Paul’s educational background includes extensive training from institutions such as the National University of Singapore and the Academy of Medicine Singapore, culminating in a Clinical Research Fellow degree from the Yong Loo Lin School of Medicine.